Hong Kong stocks healthcare continues to break through! Huaxia Hong Kong Stock Connect healthcare ETF surges over 4% intraday

NightAirdropper · 2026-03-25T13:03:47+00:00

On March 24, the Hong Kong stock healthcare ETF from Huaxia rose strongly with gains exceeding 4%. Benefiting from positive earnings results, pharmaceutical stocks surged collectively. BOCOM International pointed out that the CXO market continues to perform well due to warming investment in innovative drugs and increased order demand. Meanwhile, Huaxia Fund unified its ETF naming format to facilitate investor searches.

NightAirdropper

2026-03-25 13:03:47

Abstract generation in progress

On March 24th, the Hong Kong Stock Medical ETF Huaxia (520510) led the gains strongly, with the afternoon rally continuing to expand. During the trading session, it once surged over 4%, ranking among the top in market-wide ETFs. Driven by positive earnings news, WuXi AppTec gained over 10%, with WuXi Biologics and WuXi Diagnostics also experiencing significant increases.

The Hong Kong Stock Connect Medical ETF Huaxia tracks the Hong Kong Stock Connect Medical Theme Index, which includes industry leaders like WuXi Biologics, WuXi AppTec, WuXi Diagnostics, and Kanglong Chemical. The ETF’s holdings have over 30% weight in CXOs, making it a leading investment among all investable market indices.

CMB International stated that, with the overall market sentiment improving for downstream innovative drugs, increased order demand, and better-than-expected performance from industry leaders, the CXO sector has continued to recover since 2025.

On March 23rd, Huaxia Fund’s on-exchange ETF abbreviations were standardized to the format “Core Elements of Investment Target + ETF + Huaxia.” After the renaming, investors can easily find related ETFs by searching for keywords of the target index, such as Hong Kong Stock Connect Medical ETF Huaxia, Hang Seng ETF Huaxia, Hang Seng Technology ETF Huaxia, and Hang Seng Internet ETF Huaxia.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.